| ²é¿´: 483 | »Ø¸´: 2 | |||
Ran2010гæ (³õÈëÎÄ̳)
|
[½»Á÷]
¡¾ÇóÖú/½»Á÷¡¿¹ØÓÚ½Íĸµ°°×¼¤Ã¸ÍøÂç²â»æµÄһЩÎÊÌâ
|
|
¿´Á˽ñÄêscienceÉϵĽÍĸÖе°°×¼¤Ã¸ºÍÁ×Ëá»¯Ã¸ÍøÂç²â»æµÄÎÄÕ ¸Õ¸Õ½Ó´¥Õâ·½ÃæµÄ¶«Î÷£¬Óкܶ಻Ã÷°×µÄ£¬Ï£Íû´ó¼Ò°ï°ïæ¹þ~ 1.Ê×ÏÈËûÓÃÕâÑùÒ»¸öÁ÷³ÌÀ´²â»æ£º ¿¹Ô¾ö¶¨±íλ±ê¼Ç£¬´Å×Ó²¶»ñ£¬Òȵ°°×ø·Ö½â£¬ÖÊÆ×²â¶¨£¬hit scoring matrix£¬ÏÔÖøÐÔ·ÖÎö£¬ÍøÂç¹¹½¨ Á½¸öµ°°×Ö®¼äµÄ·´Ó¦ÊÇÔõô±»È·¶¨µÄ£¿hit scoring matrixÊÇʲô£¬Æäºá×ø±êΪbaits£¬×Ý×ø±êΪhits£¬·Ö±ð´ú±íʲôº¬Ò壿 2.TOR£¨target of rapamycin£©º¬Á¿µÄÉÏÉý»áµ¼Ö¸ü¸ßµÄrapamycinµÖ¿¹Á¦Ã´£¿Èç¹ûTOR complexµÄijЩ³É·ÖºÍÆäËû¼¤Ã¸»òÁ×Ëữø·´Ó¦£¬»áµ¼Öµֿ¹Á¦±ä»¯Ã´£¿ 3.NNK1£¨NÍøÂ缤ø£©ÓëTOR complex1µÄ³É·Öµ°°×ºÍGdh2£¨glu ·Ö½âø£¬·Ö½â²úÎïÊǰ±ºÍͪÎì¶þËᣩÏ໥×÷Óá£NNK1µÄ¹ýÁ¿±í´ï»áµ¼Ö¶ÔrapamycinÃô¸Ð¡£ ÏÖÏóÊÇÔÚglu×÷ΪΨһµªÔ´µÄÅàÑø»ùÉÏ£¬gdhȱÏÝÐÍ»á±íÏÖ³örapamycinµÖ¿¹Á¦ Äܰï½âÊÍÒ»ÏÂÔÒòô£¿ÊÇÒòΪglu×÷ΪµªÔ´Ê±£¬Gdh2µÄ±í´ïÁ¿»áÉý¸ß£¬´Ó¶øÓÕµ¼NNK1µÄ±í´ïÉý¸ßô£¿ 4.×îºóÒ»¸öÎÊÌ⣬TOR complex1 effector Ure2 ͨ¹ýÔÚϸ°ûÖÊÄÚ sequestering ת¼Òò×ÓGln3 À´µ÷½Únitrogen catabolite response£¬ Õâ¾ä»°µÄÓ¢ÎIJ¿·ÖÎÒ²»Ì«Ã÷°×£¬Âé·³°ï½âÊÍÏ£¨²»ÊÇ·Òë¹þ£©~ ÎÊÌâºÜ¶à£¬Âé·³´ó¼ÒÁË£¬Ð»Ð»ÏÈ~ |
» ²ÂÄãϲ»¶
276Çóµ÷¼Á¡£ÓаëÄêµç³ØºÍ°ëÄê¸ß·Ö×Óʵϰ¾Àú
ÒѾÓÐ8È˻ظ´
½ÓÊÕ2026˶ʿµ÷¼Á(ѧ˶+ר˶)
ÒѾÓÐ3È˻ظ´
²ÄÁÏÓ뻯¹¤¿¼Ñе÷¼Á
ÒѾÓÐ3È˻ظ´
081700 µ÷¼Á 267·Ö
ÒѾÓÐ3È˻ظ´
Ò»Ö¾Ô¸ÖØÇì´óѧ085700×ÊÔ´Óë»·¾³£¬×Ü·Ö308Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
336»¯¹¤µ÷¼Á
ÒѾÓÐ4È˻ظ´
08¹¤Ñ§µ÷¼Á
ÒѾÓÐ10È˻ظ´
263Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
298Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
¿¼Ñл¯Ñ§308·ÖÇóµ÷¼Á
ÒѾÓÐ6È˻ظ´
ÁÖµt
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 4244.4
- É¢½ð: 1250
- Ìû×Ó: 644
- ÔÚÏß: 172.9Сʱ
- ³æºÅ: 703464
- ×¢²á: 2009-02-18
- ÐÔ±ð: GG
- רҵ: ¼ÆËã»úÈí¼þ
2Â¥2010-11-07 21:51:52
Ran2010
гæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 48.7
- Ìû×Ó: 10
- ÔÚÏß: 4Сʱ
- ³æºÅ: 1122822
- ×¢²á: 2010-10-14
- רҵ: ÉúÎïÐÅϢѧ
|
a globla protein kinase and phosphatase interaction network in yeast http://www.ncbi.nlm.nih.gov/pubmed/20489023 |
3Â¥2010-11-08 07:15:59













»Ø¸´´ËÂ¥